NASDAQ:RAIN Rain Oncology (RAIN) News Today $1.10 -0.04 (-3.51%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$1.05▼$1.1550-Day Range$1.10▼$9.9352-Week Range$1.05▼$14.48Volume1.90 million shsAverage Volume2.75 million shsMarket Capitalization$40.00 millionP/E RatioN/ADividend YieldN/APrice Target$16.44 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Rain Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for RAIN and its competitors with MarketBeat's FREE daily newsletter. Email Address RAIN Media Mentions By Week RAIN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RAIN News Sentiment▼-0.400.72▲Average Medical News Sentiment RAIN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RAIN Articles This Week▼404▲RAIN Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRain Oncology Inc. to Post Q2 2023 Earnings of ($0.51) Per Share, SVB Leerink Forecasts (NASDAQ:RAIN)americanbankingnews.com - May 27 at 1:40 AMHC Wainwright Research Analysts Boost Earnings Estimates for Rain Oncology Inc. (NASDAQ:RAIN)americanbankingnews.com - May 27 at 1:40 AMCitigroup Downgrades Rain Oncology (RAIN)msn.com - May 25 at 7:54 PMRain Oncology (NASDAQ:RAIN) Downgraded by Citigroup to "Neutral"americanbankingnews.com - May 25 at 4:00 AMRain Oncology (NASDAQ:RAIN) Stock Rating Lowered by SVB Leerinkamericanbankingnews.com - May 24 at 7:29 AMRain Oncology (NASDAQ:RAIN) Rating Lowered to Market Perform at SVB Leerinkamericanbankingnews.com - May 24 at 6:40 AMRain Oncology (NASDAQ:RAIN) Rating Lowered to Market Perform at Lifesci Capitalamericanbankingnews.com - May 24 at 5:52 AMRain Oncology (NASDAQ:RAIN) Cut to "Neutral" at Piper Sandleramericanbankingnews.com - May 24 at 2:54 AMRain Oncology (NASDAQ:RAIN) Stock Rating Lowered by Oppenheimeramericanbankingnews.com - May 24 at 2:54 AMRain Oncology (NASDAQ:RAIN) Rating Lowered to Neutral at Guggenheimamericanbankingnews.com - May 24 at 2:17 AMJonesTrading Downgrades Rain Oncology (RAIN)msn.com - May 23 at 7:35 PMRain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Viewsmarkets.businessinsider.com - May 23 at 1:36 PMHC Wainwright Downgrades Rain Oncology (NASDAQ:RAIN) to Neutralamericanbankingnews.com - May 23 at 8:46 AMMizuho Securities Keeps Their Buy Rating on Rain Therapeutics (RAIN)markets.businessinsider.com - May 22 at 9:25 PMEast Bay cancer drug maker's stock plummets on late-stage trial resultsbizjournals.com - May 22 at 9:25 PMUnusual Put Option Trade in Rain Oncology (RAIN) Worth $310.04Kmsn.com - May 22 at 9:25 PMLifeSci Capital Reaffirms Their Hold Rating on Rain Therapeutics (RAIN)markets.businessinsider.com - May 22 at 4:25 PMRain Oncology falls 81% after Phase 3 setback for lead assetseekingalpha.com - May 22 at 4:25 PMRain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readoutmsn.com - May 22 at 4:25 PMWhy Shares of Rain Oncology Are Plummeting Todayfinance.yahoo.com - May 22 at 4:25 PMRain Oncology Inc.: Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcomafinanznachrichten.de - May 22 at 9:21 AMRain Oncology Shares Fall as Lead Product Candidate's Trial Misses Primary Endpointmarketwatch.com - May 22 at 9:21 AMRain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcomafinance.yahoo.com - May 22 at 9:21 AMmarketbeat.com - May 22 at 7:56 AM‘Not for everybody’: Why Phil Mickelson wears sunglasses in the rainmsn.com - May 20 at 8:57 PMDenver weather: Widespread rain on Thursday, Fridaymsn.com - May 18 at 4:18 PMRain Therapeutics (RAIN) Gets a Buy from SVB Securitiesmarkets.businessinsider.com - May 15 at 10:58 AMBrokerages Set Rain Oncology Inc. (NASDAQ:RAIN) PT at $16.44americanbankingnews.com - May 13 at 2:24 AMEF Hutton Reiterates Rain Oncology (RAIN) Buy Recommendationmsn.com - May 12 at 7:19 PMJonesTrading Remains a Buy on Rain Therapeutics (RAIN)markets.businessinsider.com - May 12 at 2:19 PMAnalysts Are Bullish on Top Healthcare Stocks: Rain Therapeutics (RAIN), Phathom Pharmaceuticals (PHAT)markets.businessinsider.com - May 12 at 9:18 AMRain Oncology Inc.: Rain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progressfinanznachrichten.de - May 12 at 4:18 AMBergen 5K Run In Memoriam Of Cancer Victim Raises $100K For Researchmsn.com - May 12 at 4:18 AMRain Oncology reports Q1 resultsseekingalpha.com - May 11 at 11:18 PMRecap: Rain Oncology Q1 Earningsmsn.com - May 11 at 11:18 PMRain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progressfinance.yahoo.com - May 11 at 6:17 PM‘Instant waterworks.’ Mom with cancer moves millions on TikTok in Texas family’s videosnews.yahoo.com - May 10 at 9:14 PMRain Oncology Inc. (NASDAQ:RAIN) Given Consensus Recommendation of "Buy" by Brokeragesmarketbeat.com - May 10 at 1:53 AM8 Famous Cancer Celebrities Who Live Up To Their Star Signyahoo.com - May 9 at 2:47 PMTriad hospital offers free skin cancer screenings Tuesdaymsn.com - May 9 at 9:47 AMRain Oncology (RAIN) to Release Quarterly Earnings on Thursdayamericanbankingnews.com - May 9 at 2:56 AMWATCH: Isolated Rain Possible Sunday, With PM Storms To Start Workweekmsn.com - May 7 at 8:22 PMRain Oncology Inc.barrons.com - May 7 at 3:21 PMRain Oncology Up 21%, Insider Buyers Are Up 25%finance.yahoo.com - May 5 at 10:50 AMRain Oncology Up 21%, Insider Buyers Are Up 25% \finance.yahoo.com - May 5 at 10:50 AMSpecial-needs high school student beats aggressive cancer; returns home from hospitalmsn.com - May 4 at 7:31 PMRain Oncology (RAIN) to Release Earnings on Thursdaymarketbeat.com - May 4 at 2:10 AMThurby to Derby forecast planner: Low chances for rain on Oaks and Derbymsn.com - May 3 at 11:28 PMThe Kuhls made it to MLB together. They’ll fight cancer the same way.msn.com - May 3 at 8:25 AMUnusual Put Option Trade in Rain Oncology (RAIN) Worth $361.08Kmsn.com - May 1 at 10:34 PM Get Rain Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for RAIN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Coya Therapeutics News Today TherapeuticsMD News Today Unity Biotechnology News Today Atreca News Today ProMIS Neurosciences News Today Corbus Pharmaceuticals News Today Medicenna Therapeutics News Today Biora Therapeutics News Today NuCana News Today SELLAS Life Sciences Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:RAIN) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.